203 related articles for article (PubMed ID: 15660212)
1. Influenza vaccines: recent advances in production technologies.
Bardiya N; Bae JH
Appl Microbiol Biotechnol; 2005 May; 67(3):299-305. PubMed ID: 15660212
[TBL] [Abstract][Full Text] [Related]
2. Vaccination against equine influenza: quid novi?
Paillot R; Hannant D; Kydd JH; Daly JM
Vaccine; 2006 May; 24(19):4047-61. PubMed ID: 16545507
[TBL] [Abstract][Full Text] [Related]
3. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
[TBL] [Abstract][Full Text] [Related]
4. Promises and challenges of live-attenuated intranasal influenza vaccines across the age spectrum: a review.
Boyce TG; Poland GA
Biomed Pharmacother; 2000 May; 54(4):210-8. PubMed ID: 10872719
[TBL] [Abstract][Full Text] [Related]
5. [Selected problems of manufacturing influenza vaccines].
Augustynowicz E
Przegl Epidemiol; 2010; 64(3):373-80. PubMed ID: 20976949
[TBL] [Abstract][Full Text] [Related]
6. Comparison of vaccines for induction of heterosubtypic immunity to influenza A virus: cold-adapted vaccine versus DNA prime-adenovirus boost strategies.
Lo CY; Wu Z; Misplon JA; Price GE; Pappas C; Kong WP; Tumpey TM; Epstein SL
Vaccine; 2008 Apr; 26(17):2062-72. PubMed ID: 18378366
[TBL] [Abstract][Full Text] [Related]
7. Use of MDCK cells for production of live attenuated influenza vaccine.
Liu J; Shi X; Schwartz R; Kemble G
Vaccine; 2009 Oct; 27(46):6460-3. PubMed ID: 19559113
[TBL] [Abstract][Full Text] [Related]
8. Translational research on vaccines: influenza as an example.
Belshe RB
Clin Pharmacol Ther; 2007 Dec; 82(6):745-9. PubMed ID: 17971813
[TBL] [Abstract][Full Text] [Related]
9. The future of cell culture-based influenza vaccine production.
Perdue ML; Arnold F; Li S; Donabedian A; Cioce V; Warf T; Huebner R
Expert Rev Vaccines; 2011 Aug; 10(8):1183-94. PubMed ID: 21854311
[TBL] [Abstract][Full Text] [Related]
10. Trivalent MDCK cell culture-derived influenza vaccine Optaflu (Novartis Vaccines).
Doroshenko A; Halperin SA
Expert Rev Vaccines; 2009 Jun; 8(6):679-88. PubMed ID: 19485748
[TBL] [Abstract][Full Text] [Related]
11. Recombinant vaccines for influenza virus.
Tripp RA; Tompkins SM
Curr Opin Investig Drugs; 2008 Aug; 9(8):836-45. PubMed ID: 18666031
[TBL] [Abstract][Full Text] [Related]
12. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
13. Development of vaccines against influenza A virus (H5N1).
Li WC; Huang YC
Chang Gung Med J; 2007; 30(4):294-304. PubMed ID: 17939259
[TBL] [Abstract][Full Text] [Related]
14. Inactivated influenza H5N1 whole-virus vaccine with aluminum adjuvant induces homologous and heterologous protective immunities against lethal challenge with highly pathogenic H5N1 avian influenza viruses in a mouse model.
Ninomiya A; Imai M; Tashiro M; Odagiri T
Vaccine; 2007 May; 25(18):3554-60. PubMed ID: 17293015
[TBL] [Abstract][Full Text] [Related]
15. New technologies for influenza vaccines.
Dormitzer PR; Tsai TF; Del Giudice G
Hum Vaccin Immunother; 2012 Jan; 8(1):45-58. PubMed ID: 22251994
[TBL] [Abstract][Full Text] [Related]
16. Attenuated influenza A viruses with modified cleavage sites in hemagglutinin as live vaccines.
Stech J
Expert Rev Vaccines; 2008 Aug; 7(6):739-43. PubMed ID: 18665773
[TBL] [Abstract][Full Text] [Related]
17. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.
Luo M; Tao P; Li J; Zhou S; Guo D; Pan Z
J Virol Methods; 2008 Dec; 154(1-2):121-7. PubMed ID: 18789973
[TBL] [Abstract][Full Text] [Related]
18. Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics.
Tian G; Zhang S; Li Y; Bu Z; Liu P; Zhou J; Li C; Shi J; Yu K; Chen H
Virology; 2005 Oct; 341(1):153-62. PubMed ID: 16084554
[TBL] [Abstract][Full Text] [Related]
19. Influenza control in the 21st century: Optimizing protection of older adults.
Monto AS; Ansaldi F; Aspinall R; McElhaney JE; Montaño LF; Nichol KL; Puig-Barberà J; Schmitt J; Stephenson I
Vaccine; 2009 Aug; 27(37):5043-53. PubMed ID: 19559118
[TBL] [Abstract][Full Text] [Related]
20. A new intranasal influenza vaccine based on a novel polycationic lipid--ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in mice.
Joseph A; Itskovitz-Cooper N; Samira S; Flasterstein O; Eliyahu H; Simberg D; Goldwaser I; Barenholz Y; Kedar E
Vaccine; 2006 May; 24(18):3990-4006. PubMed ID: 16516356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
